20. Singer EJ, Syndulko K, Fahy-Chandon B, et al. Intrathecal IgG 25.
synthesis and albumin leakage are increased in subjects with
HIV-1 neurologic disease. J Acquir Immune Defic Syndr 1994;
7:265–271.
21. Higazi A, Cohen RL, Henkin J, et al. Enhancement of the en- 26.
zymatic activity of single-chain urokinase plasminogen activator
by soluble urokinase receptor. J Biol Chem 1995;270:
17375–17380.
22. Chavakis T, Kanse SM, Yutzy B, et al. Vitronectin concentrates
27.
proteolytic activity on the cell surface and extracellular matrix
by trapping soluble urokinase receptor-urokinase complexes.
Blood 1998;91:2305–2312.
23. Higazi AA, Bdeir K, Hiss E, et al. Lysis of plasma clots by
urokinase-soluble urokinase receptor complexes. Blood 1998; 28.
92:2075–2083.
24. Rosenberg GA, Kornfeld M, Estrada E, et al. TIMP-2 reduces
proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res 1992;576:203–207.
